Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Lobo

Showing results (21-30 of 302) with videos related to

Pageof 31
Sort By:
American Journal of Obstetrics and Gynecology|September 1, 1995
Benefits and risks of estrogen replacement therapyR A Lobo
Endocrinology and Metabolism Clinics of North America|December 1, 1988
The role of neurotransmitters and opioids in polycystic ovarian syndromeR A Lobo
International Journal of Fertility|January 1, 1988
The androgenicity of progestational agentsR A Lobo
Climacteric : the Journal of the International Menopause Society|October 27, 2007
Postmenopausal hormones and coronary artery disease: potential benefits and risksR A Lobo
Climacteric : the Journal of the International Menopause Society|October 9, 2009
The risk of stroke in postmenopausal women receiving hormonal therapyR A Lobo
Fertility and Sterility|June 1, 1995
A disorder without identity: "HCA," "PCO," "PCOD," "PCOS," "SLS". what are we to call it?!R A Lobo
The Medical Journal of Australia|July 17, 2001
Priorities in polycystic ovary syndromeR A Lobo
Obstetrical & Gynecological Survey|July 24, 2001
Androgens in postmenopausal women: production, possible role, and replacement optionsR A Lobo
Advances in Endocrinology and Metabolism|January 1, 1995
Polycystic ovary syndrome/hyperandrogenic chronic anovulationR A Lobo
Clinical Chemistry|January 1, 1995
Investigating the cause of hirsutism and acne in womenR A Lobo
Pageof 31

Showing results (21-30 of 302) with videos related to

Sort By:
Pageof 31
American Journal of Obstetrics and Gynecology|September 1, 1995
Benefits and risks of estrogen replacement therapyR A Lobo
Endocrinology and Metabolism Clinics of North America|December 1, 1988
The role of neurotransmitters and opioids in polycystic ovarian syndromeR A Lobo
International Journal of Fertility|January 1, 1988
The androgenicity of progestational agentsR A Lobo
Climacteric : the Journal of the International Menopause Society|October 27, 2007
Postmenopausal hormones and coronary artery disease: potential benefits and risksR A Lobo
Climacteric : the Journal of the International Menopause Society|October 9, 2009
The risk of stroke in postmenopausal women receiving hormonal therapyR A Lobo
Fertility and Sterility|June 1, 1995
A disorder without identity: "HCA," "PCO," "PCOD," "PCOS," "SLS". what are we to call it?!R A Lobo
The Medical Journal of Australia|July 17, 2001
Priorities in polycystic ovary syndromeR A Lobo
Obstetrical & Gynecological Survey|July 24, 2001
Androgens in postmenopausal women: production, possible role, and replacement optionsR A Lobo
Advances in Endocrinology and Metabolism|January 1, 1995
Polycystic ovary syndrome/hyperandrogenic chronic anovulationR A Lobo
Clinical Chemistry|January 1, 1995
Investigating the cause of hirsutism and acne in womenR A Lobo
Pageof 31